AFP and Cirrhosis: Previous studies have shown that the cutoff values of AFP for HCC surveillance are lower in HBV-related cirrhosis patients receiving nucleos(t)ide analogue therapy [40] and HCV-related cirrhosis patients treated with DAAs [41].